The significance of ovarian fibrosis

David A. Landry; Het T. Vaishnav; Barbara C. Vanderhyden

doi:10.18632/oncotarget.27822

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Perspectives:

The significance of ovarian fibrosis

PDF | Full Text | How to cite

Oncotarget. 2020; 11:4366-4370. https://doi.org/10.18632/oncotarget.27822

Metrics: PDF 1573 views | Full Text 2877 views | ?

David A. Landry, Het T. Vaishnav and Barbara C. Vanderhyden _

Abstract

David A. Landry1, Het T. Vaishnav1 and Barbara C. Vanderhyden1

1 Cancer Therapeutics Program, Ottawa Hospital Research Institute and Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Canada

Correspondence to:

Barbara C. Vanderhyden,

email:

bvanderhyden@ohri.ca

Keywords: ovarian fibrosis; ovarian cancer; female reproduction; fertility; metformin

Received: October 30, 2020 Accepted: November 03, 2020 Published: November 24, 2020

Copyright: © 2020 Landry et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

ABSTRACT

Ovarian aging is associated with significant changes in the structural organization of collagen, resulting in ovarian fibrosis. In many other tissues, fibrosis increases risks associated with tumorigenesis and metastasis. Thus, it is possible that ovarian fibrosis increases the risk of ovarian cancer by creating a microenvironment more permissive to tumor growth. In this research perspective, we review the impact of female reproduction on the development of ovarian fibrosis and the contributions of genetic and hormonal disruptions such as BRCA mutation, polycystic ovarian syndrome, and infertility to structural changes in the ovary and their relative risk of ovarian cancer. We also explore new fundamental questions in the field of ovarian fibrosis and possible prevention strategies such as metformin.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 27822

Publication Alerts

Oncoscience

Post-Publication Promotion

Research Perspectives:

The significance of ovarian fibrosis

Abstract